Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarantus Bioscience Holdings Inc (OTCQX US:AMBS)

2.07
Delayed Data
As of 3:52pm ET
 -0.09 / -4.17%
Today’s Change
1.60
Today|||52-Week Range
17.10
-83.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$17.0M

Company Description

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
655 Montgomery Street
San Francisco California 94111
P:(415) 688-4484
Investor Relations:
14087372734101

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Elise BrownellSenior VP-Operations & Program Management
Robert Edward FarrellChief Financial Officer
John W. CommissiongDirector & Chief Scientific Officer
F. Randall GrimesHead-Sponsored Research